Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Endocrine 1Dermatologic 1

Conditions

Breast Neoplasms 33Prostatic Neoplasms 8Triple Negative Breast Neoplasms 4Pancreatic Neoplasms 3Endometrial Neoplasms 3Carcinoma, Renal Cell 3Uterine Cervical Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pleural Effusion, Malignant 2Ovarian Neoplasms 2Neoplasms 2Mouth Neoplasms 2Lymphedema 2Liver Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia 2Infertility 2Hodgkin Disease 2Fibrosis 2Carcinoma, Medullary 2Carcinoma, Intraductal, Noninfiltrating 2Anatomic Stage III Breast Cancer AJCC v8 2Anatomic Stage I Breast Cancer AJCC v8 2Uterine Hemorrhage 1Unspecified Adult Solid Tumor, Protocol Specific 1Thyroid Nodule 1Thyroid Cancer, Papillary 1Stomatitis 1Somatostatinoma 1Soft Tissue Neoplasms 1

Interventions

Everolimus 3Temozolomide 2Leucovorin 2Fluorouracil 2Bevacizumab 2vatalanib 1temsirolimus 1regorafenib 1pentetreotide 1pazopanib 1folfirinox 1Vinorelbine 1Thalidomide 1Sirolimus 1Oxaliplatin 1Octreotide 1Irinotecan 1High-Energy Shock Waves 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Doxorubicin 1Cytokines 1Capecitabine 14-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Islet Cell × High-Energy Shock Waves × Clear all
NCT00655655 2024-08-21

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors

Mayo Clinic

Phase 1 Completed
96 enrolled
DermatologicEndocrineGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Glucagonoma, Insulinoma, Melanoma, Pheochromocytoma, Somatostatinoma, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Islet Cell, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡